GSK3B and Insulin resistance: Recent research has shown that EC ADAM17 can cleave the insulin receptor ectodomain, leading to cellular insulin resistance [64], which could exacerbate insulin resistance, with the initial upregulation of ADAM17 potentially leading to further GSK3β activation.